ET Intelligence Group: Corona Remedies, a pharmaceutical company, plans to raise Rs 655.4 crore through an offer for sale. The promoter group’s stake will drop from 72.5% to 69% after the IPO. The company focuses on the specialist doctors, which is driving revenue growth faster than the Indian pharmaceutical market (IPM). Specialists accounted for 75.8% […]
